Right ventricular myocardial infarction: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 2: Line 2:
{| class="infobox" style="float:right;"
{| class="infobox" style="float:right;"
|-
|-
| [[File:Siren.gif|30px|link=Right ventricular myocardial infraction resident survival guide]]|| <br> || <br>
| [[File:Siren.gif|30px|link=Right ventricular myocardial infarction resident survival guide]]|| <br> || <br>
| [[Right ventricular myocardial infraction resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
| [[Right ventricular myocardial infarction resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
|}
|}
{{Right ventricular myocardial infarction}}
{{Right ventricular myocardial infarction}}

Latest revision as of 14:58, 17 March 2014



Resident
Survival
Guide

Right ventricular myocardial infarction Microchapters

Home

Overview

Pathophysiology

Pathophysiology of Reperfusion
Gross Pathology
Histopathology

Causes

Differentiating Right ventricular myocardial infarction from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

Coronary Angiography

Other Imaging Findings

Treatment

Initial Care

Pharmacological Reperfusion

Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI)
Fibrinolysis

Mechanical Reperfusion

The Importance of Reducing Door-to-Balloon Times
Primary PCI
Adjunctive and Rescue PCI
Rescue PCI
Facilitated PCI
Adjunctive PCI
CABG
Management of Patients Who Were Not Reperfused
Assessing Success of Reperfusion

Antithrombin Therapy

Antithrombin Therapy
Unfractionated Heparin
Low Molecular Weight Heparinoid Therapy
Direct Thrombin Inhibitor Therapy
Factor Xa Inhibition
DVT Prophylaxis
Long Term Anticoagulation

Antiplatelet Agents

Aspirin
Thienopyridine Therapy
Glycoprotein IIbIIIa Inhibition

Other Initial Therapy

Inhibition of the Renin-Angiotensin-Aldosterone System
Magnesium Therapy
Glucose Control
Calcium Channel Blocker Therapy

Right ventricular myocardial infarction On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Right ventricular myocardial infarction

CDC on Right ventricular myocardial infarction

Right ventricular myocardial infarction in the news

Blogs on Right ventricular myocardial infarction

Directions to Hospitals Treating Right ventricular myocardial infarction

Risk calculators and risk factors for Right ventricular myocardial infarction

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Priyamvada Singh, M.D. [3]

Overview

Pathophysiology

Pathophysiology of Reperfusion | Gross Pathology | Histopathology

Causes

Differentiating Right ventricular myocardial infarction from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria | History and Symptoms | Physical Examination | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | Coronary Angiography | Other Imaging Findings

Treatment

Initial Care

Pharmacologic Reperfusion: Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) | Fibrinolysis

Mechanical Reperfusion: The Importance of Reducing Door-to-Balloon Times | Primary PCI | Adjunctive and Rescue PCI | Rescue PCI | Facilitated PCI | Adjunctive PCI | CABG | Management of Patients Who Were Not Reperfused | Assessing Success of Reperfusion

Antithrombin Therapy: Antithrombin Therapy | Unfractionated Heparin | Low Molecular Weight Heparinoid Therapy | Direct Thrombin Inhibitor Therapy | Factor Xa Inhibition | DVT Prophylaxis | Long Term Anticoagulation

Antiplatelet Agents: Aspirin | Thienopyridine Therapy | Glycoprotein IIbIIIa Inhibition

Other Initial Therapy: Inhibition of the Renin-Angiotensin-Aldosterone System | Magnesium Therapy | Glucose Control | Calcium Channel Blocker Therapy


Template:WikiDoc Sources